JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

Hologic Inc

Geschlossen

BrancheGesundheitswesen

74.02 0.16

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

73.84

Max

74.1

Schlüsselkennzahlen

By Trading Economics

Einkommen

212M

195M

Verkäufe

19M

1B

KGV

Branchendurchschnitt

28.98

37.461

EPS

1.08

Gewinnspanne

19.037

Angestellte

7,063

EBITDA

341M

334M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+5.42% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

3. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

1.3B

16B

Vorheriger Eröffnungskurs

73.86

Vorheriger Schlusskurs

74.02

Nachrichtenstimmung

By Acuity

25%

75%

51 / 371 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Hologic Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

21. Okt. 2025, 13:20 UTC

Akquisitionen, Fusionen, Übernahmen

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion

27. Mai 2025, 18:46 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

Hologic Shares Up Following Report of Buyout Offer From TPG, Blackstone

21. Okt. 2025, 16:36 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Hologic Seen as Prime Take-Private Candidate -- Market Talk

21. Okt. 2025, 13:05 UTC

Akquisitionen, Fusionen, Übernahmen

Blackstone, TPG to Buy Hologic for Up to $18.3B

21. Okt. 2025, 12:50 UTC

Akquisitionen, Fusionen, Übernahmen

Hologic Plans to File Form 10-K for Fiscal 2025 With the SEC in Late Nov >HOLX

21. Okt. 2025, 12:49 UTC

Akquisitionen, Fusionen, Übernahmen

Hologic Does Not Intend to Provide Fincl Guidance for FY26 in Upcoming 4Q Results Release

21. Okt. 2025, 12:48 UTC

Akquisitionen, Fusionen, Übernahmen

Hologic Merger Agreement Includes a 45-Day 'Go-Shop' Period >HOLX

21. Okt. 2025, 12:48 UTC

Akquisitionen, Fusionen, Übernahmen

Hologic Will Continue to Operate Under the Hologic Name and Brand >HOLX

21. Okt. 2025, 12:48 UTC

Akquisitionen, Fusionen, Übernahmen

Hologic Will Maintain Its Headquarters in Marlborough, Massachusetts >HOLX

21. Okt. 2025, 12:47 UTC

Akquisitionen, Fusionen, Übernahmen

Blackstone's Private Equity Strategy for Individual Investors Is Also Expected to Invest as Part of Transaction

21. Okt. 2025, 12:46 UTC

Akquisitionen, Fusionen, Übernahmen

Blackstone and TPG Secured Committed Financing From Citi, Bank of Amer, Barclays, Royal Bank of Canada and SMBC

21. Okt. 2025, 12:46 UTC

Akquisitionen, Fusionen, Übernahmen

Blackstone and TPG Have Secured Committed Financing for the Transaction >HOLX

21. Okt. 2025, 12:45 UTC

Akquisitionen, Fusionen, Übernahmen

Hologic: Transaction Includes Significant Minority Investments From Subsidiary of Abu Dhabi Investment Authority and an Affil of GIC >HOLX

21. Okt. 2025, 12:45 UTC

Akquisitionen, Fusionen, Übernahmen

Hologic: Purchase Price Represents Premium of About 46% to Closing Price on May 23 >HOLX

21. Okt. 2025, 12:45 UTC

Akquisitionen, Fusionen, Übernahmen

Hologic: Non-tradable CVR Would Be Issued to Holders at Closing and Paid Following Achievement of Certain Global Rev Goals for Breast Health Business in FY26, FY27

21. Okt. 2025, 12:44 UTC

Akquisitionen, Fusionen, Übernahmen

Blackstone and TPG Will Acquire Hologic Shrs for $76/Shr in Cash Plus Non-Tradable CVR to Get Up to $3/Shr for Total of Up to $79/Shr in Cash >HOLX

21. Okt. 2025, 12:42 UTC

Akquisitionen, Fusionen, Übernahmen

Hologic: Transaction Will Help Strengthen Leadership in Women's Health and Accelerate Growth >HOLX

21. Okt. 2025, 12:42 UTC

Akquisitionen, Fusionen, Übernahmen

Hologic to Be Acquired by Funds Managed by Blackstone Deal and TPG in Deal With Enterprise Value of Up to $18.3 B >BX HOLX

27. Mai 2025, 20:07 UTC

Akquisitionen, Fusionen, Übernahmen

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27. Mai 2025, 19:06 UTC

Akquisitionen, Fusionen, Übernahmen

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27. Mai 2025, 18:26 UTC

Akquisitionen, Fusionen, Übernahmen

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 19%. -- Barrons.com

Peer-Vergleich

Kursveränderung

Hologic Inc Prognose

Kursziel

By TipRanks

5.42% Vorteil

12-Monats-Prognose

Durchschnitt 78 USD  5.42%

Hoch 94 USD

Tief 69 USD

Basierend auf 13 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Hologic Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

13 ratings

3

Buy

10

Halten

0

Sell

Technischer Score

By Trading Central

52.69 / 58.605Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Weak Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

51 / 371 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Hologic Inc

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
help-icon Live chat